SCHEMBL6257465

SCHEMBL6257465

CC(CNC(=O)OCc1ccccc1)n1ncc2ccc(O)c(C=O)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.39
ATM Q13315 1/20 0.37
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 1/20 0.37
GFER P55789 1/20 0.37
PTPN1 P18031 1/20 0.37
CTSK P43235 3/20 0.36
CTSS P25774 2/20 0.36
SYK P43405 1/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
PSMB1 P20618 1/20 0.36
PSMB5 P28074 1/20 0.36
PSMB2 P49721 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6252719 1.00 MAPK1 (0.39) MAPK1ATMLMNASMN1; SMN2TP53
SCHEMBL5796714 0.87 MAPK1 (0.38) MAPK1ATMLMNASMN1; SMN2TP53
SCHEMBL6255179 0.86 MAPK1 (0.38) MAPK1ATMLMNASMN1; SMN2TP53
SCHEMBL3960378 0.80 ATM (0.42) MAPK1ATMCTSKCTSSCTSL
SCHEMBL3962685 0.80 ATM (0.42) MAPK1ATMCTSKCTSSCTSL
SCHEMBL7009702 0.79 KMO (0.44) ATMLMNASMN1; SMN2TP53GFER
SCHEMBL6254005 0.76 ATM (0.41) MAPK1ATMLMNASMN1; SMN2TP53
SCHEMBL7008755 0.76 CA1 (0.46) ATMLMNACTSKCTSSCTSL
SCHEMBL6250919 0.76 ATM (0.41) MAPK1ATMLMNASMN1; SMN2TP53
SCHEMBL6252579 0.75 ATM (0.40) MAPK1ATMLMNASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005053688-A1 SUBSTITUTED FURO[2,3-G] INDAZOLES FOR THE TREATMENT OF GLAUCOMA ALCON, INC. (CH) 2005-06-16 WO disclosed